Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells...
Supports Development of Ancilia’s Unique Platform that Harnesses CRISPR’s Natural Function to Increase the Utility of Live Bacterial Products for Therapeutic...
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a company focused on cellular and cell-derived therapeutics for the...
RAMAT GAN, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing...
Lighten up with Bioactive Fiber! Manitoba Harvest and Brightseed unveil new products and research in support of digestive and metabolic...
Castellum, Inc. Issues Letter to Shareholders Castellum, Inc. (the "Company" or "Castellum") (NYSE-American: CTM), a cybersecurity, electronic warfare, and software...
Company Announcement Net sales of DARZALEX® in the second quarter of 2024 totaled USD 2,878 millionGenmab receives royalties on worldwide...
Will connect innovators with investment, hands-on expertise and the leading biopharmaceutical manufacturers DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) --...
Robust reduction in anti-VEGF injection treatment burden through Week 24 achieved in 30 patients at planned Phase 3 dose (3E10...
BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer...
WOODSTOCK, Va., July 17, 2024 (GLOBE NEWSWIRE) -- Shenandoah Valley seniors and their families have something to celebrate: The Warren,...
- 6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class...
EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg Engineering and continues to make moves in the med-tech space...
EssilorLuxottica to Acquire Supreme® from VF Corporation Paris, France and Denver, CO (17 July 2024 – 8am CEST) - EssilorLuxottica,...
Company strengthens sustainability practices prior to commercializationEINDHOVEN, the Netherlands, July 17, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD),...
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE...
After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p <...
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities...
BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second...
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change...